Today: 1 May 2026
Browse Category

NYSE:KEY 29 October 2025 - 2 April 2026

KeyBank Fraud Controls in Focus After Ohio Robbery and Foiled $5,000 Check Scam

KeyBank Fraud Controls in Focus After Ohio Robbery and Foiled $5,000 Check Scam

Police arrested a man accused of robbing a KeyBank branch in Miami Township, Ohio, days before the bank highlighted a separate $5,000 check-fraud attempt stopped by its Positive Pay system. The incidents come as KeyCorp prepares to report first-quarter results on April 16. Federal data show check fraud remains widespread, with 63% of surveyed companies targeted in 2024 and 91% still using checks. KeyBank shares opened at $20.34 Thursday.
2 April 2026
·
KeyBank Leadership Moves Hit Ohio and Alaska as Jim Hoffman Takes ProMedica Chair, Garet Plantz Wins New Role

KeyBank Leadership Moves Hit Ohio and Alaska as Jim Hoffman Takes ProMedica Chair, Garet Plantz Wins New Role

Jim Hoffman, former KeyBank Michigan and Northwest Ohio head, has been named chair of ProMedica’s board of trustees, replacing Kurt Darrow. Separately, KeyBank promoted Garet Plantz to small business relationship manager for Alaska. ProMedica’s leadership change follows a Moody’s upgrade to Baa3 in December. KeyBank reported $184 billion in assets at the end of 2025.
21 March 2026
·
KeyCorp Slashes Prime Lending Rate to 7.00% – Here’s What Borrowers & Investors Need to Know

KeyCorp Slashes Prime Lending Rate to 7.00% – Here’s What Borrowers & Investors Need to Know

KeyCorp said Oct. 29 it will cut its prime lending rate to 7.00% from 7.25%, effective Oct. 30, following the Federal Reserve’s second rate cut of 2025. Webster Bank matched the move. KeyCorp, a Cleveland-based regional bank with $187 billion in assets, trades near $17.40. Analyst price targets for KEY range from $19 to $24, with recent target hikes from UBS and Morgan Stanley.
29 October 2025
·

Stock Market Today

  • Seaport Therapeutics CEO Rings Nasdaq Opening Bell
    May 1, 2026, 5:30 PM EDT. Seaport Therapeutics, a clinical-stage company focusing on neuropsychiatric medicines, marked a milestone at the Nasdaq MarketSite in Times Square. Daphne Zohar, founder and CEO, rang the Opening Bell to commemorate the event. The company, listed as SPTX, is advancing treatments in mental health, spotlighting innovation within the biopharma sector on Nasdaq's platform.

Latest article

Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

1 May 2026
Zscaler shares climbed 7% to $139.81 Friday despite a price-target cut by Citizens JMP to $210. The move followed a sector rally after Atlassian raised its forecast. Zscaler reported 26% revenue growth last quarter and expanded AI security features in its GovCloud product. Customers remain cautious on large deals, with longer approval times noted.
Xanadu Quantum Technologies Stock Gets First Big Test as Q1 Results Date Lands

Xanadu Quantum Technologies Stock Gets First Big Test as Q1 Results Date Lands

1 May 2026
Xanadu Quantum Technologies will report first-quarter results May 14, its first earnings since going public last month. Shares closed at $36.12 Friday, up $7.05, with 4.28 million traded. The company posted a $70.7 million net loss in 2025 and raised $302 million via a SPAC merger. Investors will watch the call for updates on spending, cash runway, and funding prospects.
Go toTop